CME Outfitters

02/03/2026

Download resources and collect credit: cmeo.me/SN-282-encore

02/02/2026

Did you know?

Many patients with IBD still don’t achieve optimal outcomes with current treatments. This CME podcast dives into investigational therapies & precision medicine to help HCPs make smarter, patient-centered treatment decisions.

🎙️ Start listening today: cmeo.me/PD-114

Inflammatory bowel disease (IBD) refers a group of chronic inflammatory disease affecting the intestines; namely, ulcerative colitis (UC) and Crohn’s disease (CD). IBD affects between 2.4 and 3.1 million adults in the United States, conferring substantial...

01/31/2026

🙌 Thank you for participating in our activity:
Unraveling the Complexities of cUTI Care: Modernizing cUTI Care with the 2025 IDSA and EAU Updates

Help extend the impact—share these key takeaways with your colleagues today! 👥📣
👉 View the activity: https://cmeo.me/WCV-125

Apply these evidence-based strategies to modernize cUTI care and improve patient outcomes:

🔹 Adopt the 2025 IDSA/EAU presentation-based classification within 60 days
Use the localized vs systemic framework in ≥70% of UTI encounters, documenting severity and systemic features (eg, fever, flank pain, CVA tenderness, instability).

🔹 Integrate the 4-step empiric therapy algorithm over the next 90 days
Guide treatment using severity, resistance risk, patient-specific factors, and local antibiogram data in ≥75% of cUTI cases.

🔹 Implement guideline-based pathways for high-risk populations within 4 months
Apply best practices for CAUTI (catheter exchange), pregnancy (inpatient IV therapy), and prostatitis in men in ≥70% of relevant encounters.

Complicated urinary tract infections (cUTIs) represent an important and growing challenge in clinical practice, affecting individual patients’ health and quality of life while exerting a substantial burden on the healthcare system. Despite being common, these infections...

01/31/2026

🙌 Thank you for participating in our activity:
Early Diagnosis and Timely Treatment in SARS-CoV-2 Infections

Help extend the impact—share these key takeaways with your colleagues today! 👥📣
👉 View the activity: https://cmeo.me/SN-280

💡 Put learning into action

Apply these evidence-based strategies to improve inpatient COVID-19 care:

🔹 Implement rapid diagnostic pathways so suspected SARS-CoV-2 inpatients receive timely testing and documented results
🔹 Initiate guideline-concordant therapy promptly for eligible patients within the recommended treatment window

Early recognition and timely treatment can make a meaningful difference in patient outcomes. 💙

Timely diagnosis and prompt initiation of treatment are critical for optimizing outcomes in patients with SARS-CoV-2 infection. Yet, despite advancements in testing and therapeutic strategies, diagnostic delays and clinical missteps persist within the inpatient setting, potentially...

01/30/2026

🙌 Thank you for participating in our activity:
Improving Time to Treatment Initiation for Viral Hepatitis (HBV, HCV, and HDV) Through Screening and Diagnosis

Help extend the impact—share these key takeaways with your colleagues today! 👥📣
👉 View the activity: https://cmeo.me/SN-274

💡 Put learning into action

Apply these strategies over the next 6 months to strengthen viral hepatitis care:

🔹 Increase HBV, HCV, and HDV screening based on region-specific guideline recommendations
🔹 Collaborate with interprofessional team members using guideline-concordant approaches to expand screening efforts
🔹 Strengthen the care continuum by linking diagnosis to timely, guideline-recommended treatment

Improving screening and diagnosis is a critical step toward faster treatment initiation and better outcomes for patients with viral hepatitis. 💙

This global discussion among experts in Asia, Europe, and North America focuses on reducing delays in treatment for hepatitis B (HBV), hepatitis C (HCV), and hepatitis D (HDV) by addressing current gaps in screening, including the...

01/30/2026

Download resources and collect credit: cmeo.me/WCV-125-encore

01/30/2026

Newly approved therapies for cervical cancer are reshaping clinical practice. But with so many options, how do you determine the best treatment plan for your patients?

📢 Join Drs. Richard Penson & Bradley Monk as they break down the latest research, including efficacy & safety data for recently approved treatments.

🎧 Tune in now: https://cmeo.me/PD-112

Recent advances in the treatment of gynecologic cancers are promising, and education is needed to ensure that both oncology and primary care clinicians, including OB/GYNs, have a thorough knowledge of the latest clinical trial data and...

01/29/2026

Not every patient needs a biopsy.

This CME Snack highlights guideline-based approaches to diagnosing and monitoring liver disease using non-invasive biomarkers and imaging tools.
Learn to interpret FIB-4, MRE, and ELF results within AASLD recommendations and apply them confidently in clinical practice.

🎓 0.5 CME credits
🔗 https://cmeo.me/SN-284

Building on the patient case introduced in Part 1, this CME Outfitters Snack takes learners through the next steps in evaluating Mr. B, a patient with relatively normal liver function tests but an indeterminate Fibrosis-4 (FIB-4)...

01/28/2026

❤️ 🧠 🩺 GLP-1 RAs impact much more than glucose.

Understand their systemic effects + how to tailor treatment in this 30-min CME.
🎥 Start now: https://cmeo.me/SN-269

GLP-1 receptor agonists (GLP-1 RAs) have become a cornerstone of type 2 diabetes (T2D) treatment, with strong endorsements from the American Diabetes Association and the American Association of Clinical Endocrinology. Despite these clear guidelines, GLP-1 RAs...

01/27/2026

Are You Providing the Best Care for Patients?
Psoriasis affects more than just the skin—it impacts quality of life, treatment accessibility, and long-term health outcomes.

✔️ Do you know how IL-23 inhibitors fit into modern treatment plans?
✔️ Are you addressing health disparities in PsO care?

Join Dr. Andrew Alexis and Dr. Susan Taylor as they break down the latest advances.

💡 Earn CME credit here: cmeo.me/SN-253

The treatment of psoriasis (PsO), a chronic, autoimmune disorder causing skin cells to build up and become inflamed, is continually evolving especially with the use of IL-23 targeting therapy. Health care practitioners (HCPs), including dermatologists and...

01/27/2026

🦠 Not all SARS-CoV-2 variants behave the same.

Regional differences can significantly affect inpatient treatment response.
This CME Outfitters Snack helps clinicians understand how variant trends impact real-world COVID-19 care.
🔗 https://cmeo.me/SN-282

The ongoing evolution of the SARS-CoV-2 virus has led to the emergence of multiple regional variants with varying genetic profiles and clinical implications. These differences significantly impact the efficacy of inpatient COVID-19 treatment strategies, including antiviral...

01/26/2026

Too often, underserved communities are excluded from clinical trials due to bias, location, and eligibility hurdles.

This CME Outfitters webcast empowers healthcare professionals to take action:

🌎 Communicate with cultural sensitivity
🧠 Address unconscious bias
🤝 Build trust through advocacy and patient navigation

🎓 Earn 1.0 CME/CE credit
👉 https://cmeo.me/WCV-108

Individuals from underserved communities often face roadblocks to clinical trial participation, including geographic limitations, socioeconomic barriers, restrictive eligibility criteria, and systemic inequities. These challenges are compounded by unconscious bias among health care professionals (HC...